Scribe Therapeutics' shares are set to begin trading on Nasdaq, following an analysis of IPO trends by HSBC.

The entities involved

• Scribe Therapeutics →

  genetic medicine therapeutics company from Alameda, California

  Nothing else this week.

• Nasdaq →

  American fully electronic stock exchange

  • Yimutian Inc. regained compliance with Nasdaq rules on October 1, 2026.18:32
  • Benchmark raised First Interstate Bank's rating while the bank continues to trade on the Nasdaq stock exchange.15:03
• HSBC →

  British multinational bank

  • HSBC upgraded Kering stock to buy, following Kering's strategy unveiling in Florence, which was driven by Gucci's performance.17:51
  • The Bank of England, FCA, and HSBC are involved in a situation where monetary policy is monitored by the FCA and market rates are influenced by central bank policy.14:33

Related events

• Freight Technologies, Inc. began trading on the Nasdaq market on October 19, 2026.Mon 15:43
• Shares of Syndax Pharmaceuticals were traded on the Nasdaq stock exchange on August 12, 2026.Aug 12
• DiaMedica Therapeutics, Inc. shares were traded on the Nasdaq exchange on October 14, 2026.Oct 15
• Regeneron Pharmaceuticals stock is traded on the Nasdaq exchange.Oct 15
• Odyssey Therapeutics, Inc. shares are being traded on the Nasdaq exchange.Sep 1